Summary:
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel
as Adjunctive Therapy in Major Depressive Disorder
Qualified Participants Must:
Male and female outpatients who are 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel